FDA looks for innovative ways to pay for MRA (Mutual Recognition Agreement) implementation
This article was originally published in Clinica
Executive Summary
The US FDA is exploring "creative funding" options that would help it foot the bill for the high cost of implementing the US-EU mutual recognition agreement.